Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
1964 and launched by Merck Sharp and Dohme under the trade name Cosmegen
2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated
In patients with cardiogenic shock
InChi: InChI=1S/C28H34N8O8/c1-2-10-42-12-14-44-15-13-43-11-9-30-22(37)8-7-21(27(40)41)34-25(38)18-3-5-19(6-4-18)31-16-20-17-32-24-23(33-20)26(39)36-28(29)35-24/h1
CAS Number: 3094-09-5
ML-290 0191584 maleate 1964 and launched by MerckML 290 is a first in class and potent relaxin insulin like family peptide receptor (RXFP1) agonist and activator of anti fibrotic genes, with an EC50 of 94 nM. ML290 is a biased allosteric agonist at the relaxin receptor RXFP1. Product information CAS Number: 1482500 76 4 Molecular Weight: 506. 49 Formula: C24H21F3N2O5S Chemical Name: 2 (propan 2 yloxy) N {2 [(3 trifluoromethanesulfonylphenyl)carbamoyl]phenyl}benzamide Smiles:
US$ 125.00
US$ 75.00
US$ 85.00
US$ 38.00
US$ 1309000.00
US$ 1095000.00
US$ 721500.00
US$ 908000.00
US$ 96.00
US$ 125.00
US$ 910000.00
US$ 1042000.00
US$ 828000.00
US$ 481000.00